Esperion Therapeutics Inc... (ESPR)
NASDAQ: ESPR
· Real-Time Price · USD
0.78
-0.11 (-12.63%)
At close: May 09, 2025, 3:43 PM
-12.63% (1D)
Bid | 0.74 |
Market Cap | 154.95M |
Revenue (ttm) | 332.31M |
Net Income (ttm) | -51.74M |
EPS (ttm) | -0.28 |
PE Ratio (ttm) | -2.79 |
Forward PE | -4.14 |
Analyst | Buy |
Ask | 0.83 |
Volume | 10,760,451 |
Avg. Volume (20D) | 4,566,593 |
Open | 0.91 |
Previous Close | 0.89 |
Day's Range | 0.73 - 0.93 |
52-Week Range | 0.73 - 3.94 |
Beta | 0.74 |
About ESPR
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ESPR
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ESPR stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsEarnings Surprise
Esperion Therapeutics has released their quartely earnings
on May 6, 2025:
2 months ago
+12.03%
Esperion Therapeutics shares are trading higher af...
Unlock content with
Pro Subscription
4 months ago
+5.58%
Esperion Therapeutics shares are trading higher after Cantor Fitzgerald initiated coverage on the stock with an Overweight rating and announced a price target of $8.

2 months ago · seekingalpha.com
Esperion Therapeutics, Inc. (ESPR) Q4 2024 Earnings Call TranscriptEsperion Therapeutics, Inc. (NASDAQ:ESPR ) Q4 2024 Earnings Conference Call March 4, 2025 8:00 AM ET Company Participants Alina Venezia - Director of Investor Relations Sheldon Koenig - President and ...